Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Diagnostic Accuracy of Combined Perfusion Index, Internal Jugular Vein Collapsibility Index and Cardiac Index in Predicting Post-Spinal Hypotension During Elective Cesarean Section

12 novembre 2026 aggiornato da: Nevine Mostafa Soliman, Menoufia University

Diagnostic Accuracy of Combined Perfusion Index, Internal Jugular Vein Collapsibility Index and Cardiac Index in Predicting Post-Spinal Hypotension During Elective Cesarean Section: A Prospective Randomized Study

compare Perfusion Index with Internal Jugular Vein Collapsibility Index (IJVCI) as a predictor for post-spinal hypotension in parturient undergoing elective caesarean section.

Panoramica dello studio

Descrizione dettagliata

  • Pre-anesthetic evaluation (History-Investigation - Examination) the day before surgery.
  • NPO: 8 hours for solids, 2 hours for clear fluids.
  • Pre-medication: Ranitidine 50 mg IV + Metoclopramide 10 mg IV, 30 minutes before anesthesia.
  • 18-G IV cannula in the non-dominant forearm.
  • Standard monitoring in the operating room: pulse oximetry (SpO2), NIBP, and ECG.
  • Baseline measurements (HR, SBP, DBP, MAP, SpO2, PI, CI, IJVCI) recorded in the supine position with 15 degree left lateral tilt.
  • All indicators will be measured in a single group before spinal anesthesia and comparisons will be made for the most sensitive maneuver in prediction of post spinal hypotension.
  • Cardiac Index (CI) will be measured using cardiometry before spinal anesthesia.
  • Perfusion Index (PI) is measured (Three consecutive readings are recorded at 1-minute intervals, will be repeated with another reading after delivery of baby).• The cut-off applied is: -
  • 3.5 or less (low risk for hypotension)
  • Greater than 3.5 (high risk for hypotension)
  • Internal Jugular Vein Collapsibility Index will be measured by Ultrasonographic assessment and is performed by using a 6-10 MHz linear ultrasound probe. (The patient is placed supine with 15 degree left lateral tilt, The probe is positioned horizontally at the right side of the neck at the level of the middle thyroid cartilage, obtaining a transverse view of the right IJV. M-mode imaging during both spontaneous and deep breathing).
  • Anteroposterior diameters of the IJV were estimated during the respiratory cycle. The IJV collapsibility index (IJVCI) was estimated via the following equation: Maximum diameter - lowest diameter/maximum diameter) 100% .
  • The mean of three consecutive measurements is recorded for each breathing mode in quite respiratory cycle.
  • Images will be saved for offline analysis.
  • The cut-off applied is:

IJVCI < 35-38% → lower risk of post-spinal hypotension IJVCI ≥ 38-40% → higher likelihood of hypotension after spinal anesthesia in CS.

  • Spinal anesthesia with intrathecal drug regimen 10-12 mg of 0.5% hyperbaric bupivacaine plus 25 micrograms (mic) Fentanyl].
  • Co-loading with Ringer's lactate at 10ml/Kg will be administrated, along with spinal anesthesia placement .Data Collection

Baseline:

  1. Patient demographic data (age, ASA physical status, comorbidities, current medications, and BMI).
  2. Hemodynamics (Heart rate- Mean Arterial Blood Pressure - Systolic Blood Pressure -Oxygen Saturation) baseline reading before induction of spinal anesthesia.
  3. Preoperative IJVCI measurement by ultrasound imaging in supine position.
  4. Preoperative Perfusion Index reading.
  5. Preoperative Cardiac index reading.

Intraoperative:

  1. Hemodynamic parameters (SBP, DBP, MAP, HR, SpO2) are recorded: -

    • Every 1 minute for the first 10 minutes,
    • Every 3 minutes until delivery,
    • Every 5 minutes thereafter until end of surgery.
  2. Total phenylephrine dose in microgram & Total Ephedrine dose (mg) [if persistent hypotension].

  3. Total IV fluid volume (mL)

  4. Total Blood loss (mL)

  5. Total Urine output (mL)

  6. Time from spinal block to delivery (min)

  7. Total time of surgery.

  8. All adverse events (nausea, vomiting, hypotension, bradycardia, oxygen desaturation) are recorded throughout.

Definition of Outcomes All outcome definitions are pre-specified and uniformly applied across all patients: -

  • Post-spinal hypotension: A fall in systolic blood pressure (SBP) below 90 mmHg.
  • Episodes are recorded from the time of spinal injection until delivery of the baby.
  • Bradycardia: Heart rate below 50 beats per minute requiring pharmacological treatment with atropine 0.01 mg/kg IV.

Treatment of PSH

  • First-line: 200 mL Ringer's lactate rapid IV infusion.
  • If SBP remains below 90 mmHg phenylephrine 25-100 microgram if persistent hypotension gives Ephedrine 5-15 mg IV bolus.
  • Bradycardia (HR < 50 bpm): Atropine 0.01 mg/kg IV.
  • All vasopressor doses and additional fluid volumes administered are recorded.

Tipo di studio

Osservativo

Iscrizione (Stimato)

50

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

      • Alexandria, Egitto
        • Reclutamento
        • Menoufia University,Faculty of Medicine
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 40 anni (Adulto)

Accetta volontari sani

No

Sessi ammissibili allo studio

Femmina

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Adults undergoing Elective Cesarean Section at Menoufia University Hospitals

Descrizione

Inclusion Criteria:

  • Full-term pregnant women undergoing elective cesarean section under spinal anesthesia (gestational age >= 37 weeks), singleton pregnancy.

    • Age: 18-40 years.
    • ASA I, II.
    • BMI: 18.5-35 kg/m2.

Exclusion Criteria:

  • • Patient refusal or inability to provide informed consent.

    • Emergency cesarean section.
    • Known contraindications to spinal anesthesia (coagulopathy, local infection, elevated ICP).
    • Baseline hypotension (SBP < 100 mmHg) prior to spinal anesthesia.
    • Hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia).
    • Placenta previa or antepartum hemorrhage.
    • Multiple pregnancy or known fetal abnormality.
    • BMI > 35 kg/m2.
    • Pre-existing cardiovascular, cerebrovascular, or significant pulmonary disease.
    • Gestational diabetes or uncontrolled systemic disease.
    • Hemoglobin < 8 g/dL or known haemoglobinopathy.
    • Peripheral vascular disease affects pulse oximetry signal quality.
    • More than two attempts at lumbar puncture or failed.
    • Inadequate spinal block.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Perfusion Index (PI) group measured by pulse oximeter
  • Perfusion Index (PI) is measured using a validated multi-parameter monitor with a pulse oximetry module (Mindray uMEC 12 or equivalent).
  • The probe is placed on the right index finger in the supine position before induction of spinal anesthesia block.
  • Three consecutive readings are recorded at 1-minute intervals.
  • These steps will be repeated with another reading after delivery of baby.
  • Then the mean value is used as the baseline PI.
  • The cut-off applied is: -
  • 3.5 or less (low risk for hypotension)
  • Greater than 3.5 (high risk for hypotension)

is measured using a validated multi-parameter monitor with a pulse oximetry module (Mindray uMEC 12 or equivalent).

  • The probe is placed on the right index finger in the supine position before induction of spinal anesthesia block.
  • Three consecutive readings are recorded at 1-minute intervals.
  • These steps will be repeated with another reading after delivery of baby.
  • Then the mean value is used as the baseline PI.
  • The cut-off applied is: -
  • 3.5 or less (low risk for hypotension)
  • Greater than 3.5 (high risk for hypotension)
Internal Jugular Vein Collapsibility Index group will be measured by ultrasonography
  • Internal Jugular Vein Collapsibility Index will be measured by Ultrasonographic assessment and is performed by using a 6-10 MHz linear ultrasound probe.
  • The patient is placed supine with 15 degree left lateral tilt.
  • The probe is positioned horizontally at the right side of the neck at the level of the middle thyroid cartilage, obtaining a transverse view of the right IJV. M-mode imaging during both spontaneous and deep breathing.
  • Anteroposterior diameters of the IJV were estimated during the respiratory cycle. The IJV collapsibility index (IJVCI) was estimated via the following equation: Maximum diameter - lowest diameter/maximum diameter) 100% [20].
  • The mean of three consecutive measurements is recorded for each breathing mode in quite respiratory cycle .
  • Images will be saved for offline analysis.
  • The cut-off applied is:

IJVCI < 35-38% → lower risk of post-spinal hypotension IJVCI ≥ 38-40% → higher likelihood of hypotension after

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Lasso di tempo
compare the diagnostic accuracy assessed by ROC curve analysis between Perfusion Index (PI) & Internal Jugular Vein Collapsibility Index (IJVCI) combined with Cardiac Index (CI) in predicting post-spinal hypotension in elective CS patients.
Lasso di tempo: • Three consecutive readings are recorded at 1-minute intervals. • These steps will be repeated with another reading after delivery of baby.
• Three consecutive readings are recorded at 1-minute intervals. • These steps will be repeated with another reading after delivery of baby.

Misure di risultato secondarie

Misura del risultato
Lasso di tempo
measure systolic arterial blood pressure changes after spinal anesthesia.
Lasso di tempo: immediately after spinal anesthesia
immediately after spinal anesthesia
Total ephedrine dose or phenylephrine dose /milligram.
Lasso di tempo: throughout the operation
throughout the operation

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 dicembre 2026

Completamento primario (Stimato)

1 dicembre 2027

Completamento dello studio (Stimato)

1 dicembre 2027

Date di iscrizione allo studio

Primo inviato

12 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

12 novembre 2026

Primo Inserito (Effettivo)

19 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

19 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

12 novembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 9/2026 ANET 53

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi